Longeveron (LGVN) Announces FDA Approves its Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Longeveron (LGVN) Announces FDA Approves its Lomecel-B for Rare Pediatric Disease Designation to Treat Life-Threatening Infant Heart Condition

Longeveron (LGVN) Halted on LUDP, Up 90%

November 19, 2021 9:33 AM EST

Longeveron (NASDAQ: LGVN) Halted on LUDP, Up 90%

... More

Longeveron (LGVN) Extends Gain, Up 100%

November 19, 2021 7:47 AM EST

Longeveron (NASDAQ: LGVN) Extends Gain, Up 100%

... More

Longeveron (LGVN) Adds to Yesterday's Gain, Up 32% Pre-Open

November 19, 2021 6:10 AM EST

Longeveron (NASDAQ: LGVN) Adds to Yesterday's Gain, Up 32% Pre-Open

Shares climbed 135% yesterday... More

Longeveron (LGVN) Halted on LUDP, Up 118%

November 18, 2021 10:16 AM EST

Longeveron (NASDAQ: LGVN) Halted on LUDP, Up 118%

... More